Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 "Sufficient life expectancy": an amazing inclusion criterion in cancer phase II-III trials.

× No keyword cloud information.

4 in total

1. Re-Evaluating Eligibility Criteria for Oncology Clinical Trials: Analysis of Investigational New Drug Applications in 2015.

Authors: Susan Jin; Richard Pazdur; Rajeshwari Sridhara
Journal: J Clin Oncol Date: 2017-10-02 Impact factor: 44.544

2. An inflammation based score can optimize the selection of patients with advanced cancer considered for early phase clinical trials.

Authors: David J Pinato; Chara Stavraka; Michael J Flynn; Martin D Forster; Séan M O'Cathail; Michael J Seckl; Rebecca S Kristeleit; David Olmos; Samantha J Turnbull; Sarah P Blagden
Journal: PLoS One Date: 2014-01-07 Impact factor: 3.240

3. Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin.

Authors: A Ploquin; D Olmos; D Lacombe; R A'Hern; A Duhamel; C Twelves; S Marsoni; R Morales-Barrera; J-C Soria; J Verweij; E E Voest; P Schöffski; J H Schellens; A Kramar; R S Kristeleit; H-T Arkenau; S B Kaye; N Penel
Journal: Br J Cancer Date: 2012-08-21 Impact factor: 7.640

4. PRognostic factor of Early Death In phase II Trials or the end of 'sufficient life expectancy' as an inclusion criterion? (PREDIT model).

Authors: Thomas Grellety; Sophie Cousin; Louis Letinier; Pauline Bosco-Lévy; Stéphanie Hoppe; Damien Joly; Nicolas Penel; Simone Mathoulin-Pelissier; Antoine Italiano
Journal: BMC Cancer Date: 2016-10-04 Impact factor: 4.430

4 in total